Question 1

Who are the top researchers at Novaliq (Germany)?

Accepted Answer

Ranked on the quality score, Sonja Krösser and Bastian Theisinger lead among researchers whose main affiliation is Novaliq (Germany).

Question 2

What are the most cited papers from Novaliq (Germany)?

Accepted Answer

The most cited paper from Novaliq (Germany) is "NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction" (Joseph Tauber et al., 2022), with 100 citations. Next come "A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease" (86) and "Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease" (76).

Question 3

Which research topics does Novaliq (Germany) publish most on?

Accepted Answer

By volume in 2022-now: Ocular Surface and Contact Lens, Corneal Surgery and Treatments, Advanced Drug Delivery Systems and Ocular Infections and Treatments.

Question 4

Which keywords describe research at Novaliq (Germany)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Dry Eye Disease, Ocular Surface, Oxidative Stress, Wound Healing, Corneal Regeneration, Tissue Engineering and Nanoparticles.

Question 5

Which fields of science does Novaliq (Germany) work in?

Accepted Answer

In all years, 70% of research at Novaliq (Germany) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (70%), Biochemistry, Genetics and Molecular Biology (11%), Pharmacology, Toxicology and Pharmaceutics (8%). It does 2.2× the world's share of Health Sciences.

Question 6

Is Novaliq (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 35% lower than in 2018-2021.